Albemarle Corp buy Jefferies Financial Group Inc.
Start price
08.12.25
/
50%
€108.32
Target price
08.12.26
€130.45
Performance (%)
-5.23%
Price
19:45
€102.65
Summary
This prediction is currently active. With a performance of -5.23%, the BUY prediction by Jefferies_Financial_ is trending in the wrong direction. This prediction currently runs until 08.12.26. The prediction end date can be changed by Jefferies_Financial_ at any time. Jefferies_Financial_ has 50% into this predictionAlbemarle is a specialty chemical company that produces and markets lithium, bromine, and other specialty chemicals globally. The company's products are used in a wide range of applications, including energy storage, flame retardants, pharmaceuticals, and agricultural solutions. Albemarle's lithium business has been a key driver of growth in recent years due to increasing demand for lithium-ion batteries used in electric vehicles and other technologies. The company has a market capitalization of around $11 billion and is listed on the New York Stock Exchange under the ticker symbol ALB.
AI-generated
Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Albemarle Corp | -1.580% | -1.580% |
| iShares Core DAX® | -0,46 % | -0,83 % |
| iShares Nasdaq 100 | -1,41 % | -3,02 % |
| iShares Nikkei 225® | -1,25 % | -7,63 % |
| iShares S&P 500 | -1,15 % | 0,59 % |
Comments by Jefferies_Financial_ for this prediction
In the thread Albemarle Corp diskutieren
Albemarle (NYSE:ALB) had its price target raised by analysts at Jefferies Financial Group Inc. from $124.00 to $152.00. They now have a "buy" rating on the stock.
Ratings data for ALB provided by MarketBeat